Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Killian S Hanlon

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Human Gene Therapy|June 15, 2021
The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal AdministrationAdam Beharry, Yi Gong, James C Kim, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in miceMiguel C Santoscoy, Paula Espinoza, Killian S Hanlon, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene ExpressionKillian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2024
In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Roberto Montoro Ferrer, et al.
Human Gene Therapy|June 28, 2023
An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain VasculatureServio H Ramirez, Jonathan F Hale, Siobhan McCarthy, et al.
Gene Therapy|June 10, 2025
Engineered AAV capsids mediate transduction of murine neurofibroma and sciatic nerveEdwina Abou Haidar, Shilpa Prabhakar, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development|December 25, 2018
Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human PrimateBence György, Elise J Meijer, Maryna V Ivanchenko, et al.
Nature Communications|October 2, 2019
High levels of AAV vector integration into CRISPR-induced DNA breaksKillian S Hanlon, Benjamin P Kleinstiver, Sara P Garcia, et al.
Nature|March 30, 2023
Genomic investigations of unexplained acute hepatitis in childrenSofia Morfopoulou, Sarah Buddle, Oscar Enrique Torres Montaguth, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Human Gene Therapy|June 15, 2021
The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal AdministrationAdam Beharry, Yi Gong, James C Kim, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Expression-based selection identifies a microglia-tropic AAV capsid for direct and CSF routes of administration in miceMiguel C Santoscoy, Paula Espinoza, Killian S Hanlon, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene ExpressionKillian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 7, 2024
In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cordKillian S Hanlon, Ming Cheng, Roberto Montoro Ferrer, et al.
Human Gene Therapy|June 28, 2023
An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain VasculatureServio H Ramirez, Jonathan F Hale, Siobhan McCarthy, et al.
Gene Therapy|June 10, 2025
Engineered AAV capsids mediate transduction of murine neurofibroma and sciatic nerveEdwina Abou Haidar, Shilpa Prabhakar, Pike See Cheah, et al.
Molecular Therapy. Methods & Clinical Development|December 25, 2018
Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human PrimateBence György, Elise J Meijer, Maryna V Ivanchenko, et al.
Nature Communications|October 2, 2019
High levels of AAV vector integration into CRISPR-induced DNA breaksKillian S Hanlon, Benjamin P Kleinstiver, Sara P Garcia, et al.
Nature|March 30, 2023
Genomic investigations of unexplained acute hepatitis in childrenSofia Morfopoulou, Sarah Buddle, Oscar Enrique Torres Montaguth, et al.
Pageof 2